Nordmark Pharma GmbH

The Role of Pharmaceutical Wholesale in Germany's Medicine Supply

Germany's pharmaceutical wholesale sector is the backbone of the country's medicine distribution system, ensuring that more than 18,000 pharmacies and thousands of hospitals receive their medicine supplies reliably, often within hours of ordering. The German wholesale model is built around a hub-and-spoke logistics system: large national full-line wholesalers (Vollsortimenter) operate central and regional warehouses that stock virtually the entire range of authorised medicines. From these warehouses, medicines are delivered to pharmacies typically two or three times per day by refrigerated vans. This high delivery frequency means that pharmacies can operate with lean stock levels while still being able to fill patient prescriptions on the same day. Germany's medicine supply chain performed robustly during the COVID-19 pandemic, demonstrating the resilience of its wholesale infrastructure. The three largest full-line wholesalers in Germany collectively hold a dominant market share, but they compete with each other and with smaller regional and specialist wholesalers.

Legal Requirements Under Section 52a AMG and EU GDP

Operating as a pharmaceutical wholesaler in Germany requires a wholesale dealer authorisation (Großhandelserlaubnis) granted by the competent pharmaceutical supervisory authority of the relevant German federal state under Section 52a of the AMG. This authorisation is not automatic and requires applicants to demonstrate compliance with a detailed set of prerequisites before trading can begin. The premises must be suitable for temperature-controlled storage, with validated temperature mapping studies for all storage areas. A documented quality management system (QMS) must be in place covering procurement, storage, pick and dispatch, complaints, returns, recalls, counterfeiting detection and self-inspections. A qualified responsible person (verantwortliche Person) with the relevant pharmaceutical or scientific qualifications must be designated and approved by the authority. After authorisation is granted, companies must comply with the EU GDP guidelines (EudraLex Volume 5), which are periodically updated. Inspections by the state pharmaceutical authority verify ongoing compliance.

Specialist Wholesale and Cold Chain Logistics in Germany

Beyond full-line wholesale, Germany has a developed specialist wholesale sector catering to specific product categories that require particular expertise or infrastructure. Cold chain wholesale is especially important for biological medicines including monoclonal antibodies, vaccines, insulin and plasma-derived products, which must be stored and transported within defined temperature ranges (typically 2 to 8 degrees Celsius). Controlled substance (Betäubungsmittel) wholesale requires additional authorisation under the Betäubungsmittelgesetz (BtMG) and is subject to strict record-keeping and security requirements. Import wholesale specialises in parallel-imported medicines, sourcing products authorised in other EU member states at lower prices and relabelling them in accordance with German regulatory requirements. Specialty pharmacy wholesale focuses on high-value oncology drugs, immunosuppressants and rare disease treatments. Each of these specialist segments requires specific expertise, infrastructure and additional regulatory permissions beyond the standard Section 52a AMG authorisation.

Medicinal Product Supply Chain Security and Falsification Protection

The integrity of the pharmaceutical supply chain is a central responsibility of pharmaceutical wholesale. Since February 2019, the EU Falsified Medicines Directive (FMD) has been fully in force: every prescription medicinal product pack carries an individual 2D data matrix code, which is scanned and verified at the wholesaler and end recipient in the national verification database (in Germany: securPharm). Temperature-critical products, including biologics, insulins and vaccines, require an unbroken cold chain (2–8 °C or frozen), which the wholesaler ensures with validated cold stores, temperature-controlled transport and temperature monitoring. Controlled substances are additionally subject to the Narcotics Act (BtMG) with strict documentation requirements. Recall management and batch traceability in accordance with GDP guidelines are mandatory. Sanoliste identifies specialist wholesalers for cold chain, controlled substances and parallel import medicines separately.